145 related articles for article (PubMed ID: 25355746)
1. Acute fibrinous organising pneumonia: a manifestation of trimethoprim-sulfamethoxazole pulmonary toxicity.
Jamous F; Ayaz SZ; Choate J
BMJ Case Rep; 2014 Oct; 2014():. PubMed ID: 25355746
[TBL] [Abstract][Full Text] [Related]
2. Trimethoprim-sulfamethoxazole-induced hepatotoxicity in a pediatric patient.
Bell TL; Foster JN; Townsend ML
Pharmacotherapy; 2010 May; 30(5):539. PubMed ID: 20412003
[TBL] [Abstract][Full Text] [Related]
3. Trimethoprim/Sulfamethoxazole-Induced Severe Lactic Acidosis: A Case Report and Review of the Literature.
Bulathsinghala M; Keefer K; Van de Louw A
Medicine (Baltimore); 2016 Apr; 95(17):e3478. PubMed ID: 27124045
[TBL] [Abstract][Full Text] [Related]
4. Trimethoprim-sulfamethoxazole-induced hyponatremia in an elderly lady with Achromobacter xylosoxidans pneumonia: Case report and insights into mechanism.
Ghali MGZ; Kim MJ
Medicine (Baltimore); 2020 Aug; 99(33):e20746. PubMed ID: 32871970
[TBL] [Abstract][Full Text] [Related]
5. Impact of prophylaxis choice on risk of pneumocystis pneumonia in children with cancer: A case-control study.
Geerlinks AV; Campigotto A; Science M; Gupta S
Eur J Cancer; 2020 Nov; 140():71-75. PubMed ID: 33059195
[TBL] [Abstract][Full Text] [Related]
6. High daily doses of trimethoprim/sulfamethoxazole are an independent risk factor for adverse reactions in patients with pneumocystis pneumonia and AIDS.
Chang HM; Tsai HC; Lee SS; Kunin C; Lin PC; Wann SR; Chen YS
J Chin Med Assoc; 2016 Jun; 79(6):314-9. PubMed ID: 27025225
[TBL] [Abstract][Full Text] [Related]
7. Interstitial lung disease during trimethoprim/sulfamethoxazole administration.
Yuzurio S; Horita N; Shiota Y; Kanehiro A; Tanimoto M
Acta Med Okayama; 2010 Jun; 64(3):181-7. PubMed ID: 20596129
[TBL] [Abstract][Full Text] [Related]
8. Incidence of Hyponatremia with High-Dose Trimethoprim-Sulfamethoxazole Exposure.
Tsapepas D; Chiles M; Babayev R; Rao MK; Jaitly M; Salerno D; Mohan S
Am J Med; 2016 Dec; 129(12):1322-1328. PubMed ID: 27542610
[TBL] [Abstract][Full Text] [Related]
9. Tolerability of low-dose sulfamethoxazole/trimethoprim for Pneumocystis jirovecii pneumonia prophylaxis in kidney transplant recipients.
Zmarlicka M; Martin ST; Cardwell SM; Nailor MD
Prog Transplant; 2015 Sep; 25(3):210-6. PubMed ID: 26308779
[TBL] [Abstract][Full Text] [Related]
10. Trimetoprim-sulfametoxazole in ventilator-associated pneumonia: a cohort study.
Strazzulla A; Postorino MC; Purcarea A; Chakvetadze C; de Farcy de Pontfarcy A; Tebano G; Pitsch A; Vong L; Jochmans S; Vinsonneau C; Monchi M; Diamantis S
Eur J Clin Microbiol Infect Dis; 2019 Nov; 38(11):2163-2169. PubMed ID: 31372907
[TBL] [Abstract][Full Text] [Related]
11. Severe Acute Respiratory Failure in Healthy Adolescents Exposed to Trimethoprim-Sulfamethoxazole.
Miller JO; Taylor J; Goldman JL
Pediatrics; 2019 Jun; 143(6):. PubMed ID: 31142578
[TBL] [Abstract][Full Text] [Related]
12. Treatment of Pneumocystis pneumonia with intermediate-dose and step-down to low-dose trimethoprim-sulfamethoxazole: lessons from an observational cohort study.
Creemers-Schild D; Kroon FP; Kuijper EJ; de Boer MG
Infection; 2016 Jun; 44(3):291-9. PubMed ID: 26471512
[TBL] [Abstract][Full Text] [Related]
13. Trimethoprim/sulfamethoxazole versus vancomycin in the treatment of healthcare/ventilator-associated MRSA pneumonia: a case-control study.
Eliakim-Raz N; Hellerman M; Yahav D; Cohen J; Margalit I; Fisher S; Zusman O; Shaked H; Bishara J
J Antimicrob Chemother; 2017 Mar; 72(3):882-887. PubMed ID: 27999052
[TBL] [Abstract][Full Text] [Related]
14. Optimal regimens of sulfamethoxazole-trimethoprim for chemoprophylaxis of Pneumocystis pneumonia in patients with systemic rheumatic diseases: results from a non-blinded, randomized controlled trial.
Utsunomiya M; Dobashi H; Odani T; Saito K; Yokogawa N; Nagasaka K; Takenaka K; Soejima M; Sugihara T; Hagiyama H; Hirata S; Matsui K; Nonomura Y; Kondo M; Suzuki F; Tomita M; Kihara M; Yokoyama W; Hirano F; Yamazaki H; Sakai R; Nanki T; Koike R; Kohsaka H; Miyasaka N; Harigai M
Arthritis Res Ther; 2017 Jan; 19(1):7. PubMed ID: 28100282
[TBL] [Abstract][Full Text] [Related]
15. Renal Insufficiency in Concert with Renin-angiotensin-aldosterone Inhibition Is a Major Risk Factor for Hyperkalemia Associated with Low-dose Trimethoprim-sulfamethoxazole in Adults.
Higashioka K; Niiro H; Yoshida K; Oryoji K; Kamada K; Mizuki S; Yokota E
Intern Med; 2016; 55(5):467-71. PubMed ID: 26935365
[TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy evaluation of low-dose trimethoprim-sulfamethoxazole for prophylaxis of Pneumocystis pneumonia in HIV uninfected patients undergoing hemodialysis: a retrospective observational study.
Yamashita K; Shimomura Y; Ikesue H; Muroi N; Yoshimoto A; Hashida T
BMC Infect Dis; 2021 Jul; 21(1):664. PubMed ID: 34238239
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness and safety of lower dose sulfamethoxazole/trimethoprim therapy for Pneumocystis jirovecii pneumonia in patients with systemic rheumatic diseases: A retrospective multicenter study.
Ohmura SI; Naniwa T; Tamechika SY; Miyamoto T; Shichi D; Kazawa N; Iwagaitsu S; Maeda S; Wada JI; Niimi A
J Infect Chemother; 2019 Apr; 25(4):253-261. PubMed ID: 30642768
[TBL] [Abstract][Full Text] [Related]
18. Trimethoprim-sulfamethoxazole-induced hyponatremia.
Dunn RL; Smith WJ; Stratton MA
Consult Pharm; 2011 May; 26(5):342-9. PubMed ID: 21733815
[TBL] [Abstract][Full Text] [Related]
19. Trimethoprim-sulfamethoxazole Induced Hyponatremia and Hyperkalemia, The Necessity of Electrolyte Follow-up in Every Patient.
Khorvash F; Moeinzadeh F; Saffaei A; Hakamifard A
Iran J Kidney Dis; 2019 Jul; 13(4):277-280. PubMed ID: 31422395
[TBL] [Abstract][Full Text] [Related]
20. Trimethoprim/sulfamethoxazole-induced hypoglycemia in a patient with acute renal failure.
Lee AJ; Maddix DS
Ann Pharmacother; 1997 Jun; 31(6):727-32. PubMed ID: 9184713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]